WVE — Wave Life Sciences Share News
0.000.00%
Last trade - 00:00- $660.71m
- $170.11m
- $42.73m
U.S. STOCKS ON THE MOVE-SurgePays, B. Riley, CarMax
U.S. STOCKS ON THE MOVE-OrganiGram, Phillips 66, SurgePays
U.S. STOCKS ON THE MOVE-Chewy, V2X, Cintas
Wave Life Sciences rises after positive data on muscle disorder drug
Brief: Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD
U.S. STOCKS ON THE MOVE-Okta, Natgas companies, UnitedHealth
Wave Life Sciences Ltd Reports Results For The Quarter Ended December 31: Earnings Summary
U.S. STOCKS ON THE MOVE-Capricor, Wave Life Sciences, EVgo
U.S. STOCKS ON THE MOVE-Wellgistics, Capricor, Wave Life Sciences
Wave Life Sciences rises after co swings to profit in Q4
Brief: Takeda Pharma Has Halted Joint Development Of Rare Disease Treatment Using Nucleic Acid Technology, Nikkei Says
Wave Life Sciences Ltd Reports Results For The Quarter Ended September 30: Earnings Summary
Wave Life Sciences Ltd Expected To Post A Loss Of 28 Cents A Share: Earnings Preview
Brief: Wave Life Sciences Plans To Have Five Galnac-RNA Editing Or GalNAc-siRNA Programs In Clinic By 2026
U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics
U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics
Wave Life Sciences up on positive early-stage data from genetic disorder therapy
Brief: Wave Life Sciences Announces First-Ever Therapeutic RNA Editing In Humans Achieved In Restoraation-2 Trial Of WVE-006 In Alpha-1 Antitrypsin Deficiency
Brief: Wave Life Sciences Units Were Notified That Takeda Did Not Intend To Exercise, Thus Elected To Terminate Option For Huntingtin Target